Susquehanna International Group
GNRX

Susquehanna International Group’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History

Susquehanna International Group’s Portfolio GNRX Stock Details GNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,614
Closed -$257K – 11296
2019
Q1 		$257K Buy
+11,614
New +$255K ﹤0.01% 7488

Susquehanna International Group's GNRX Position: Q2 2019 in Review

Susquehanna International Group sold out of VanEck Vectors Generic Drugs ETF (GNRX) in Q2 2019, closing a stake of 11,614 shares — an estimated $257K sold.

Susquehanna International Group first reported a position in GNRX in Q1 2019 and held it in 1 quarter. The position peaked at $257K in Q1 2019. 0 funds tracked by Wall St. Rank hold GNRX as of Q2 2019.

  • Susquehanna International Group reported no remaining VanEck Vectors Generic Drugs ETF position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 11,614 VanEck Vectors Generic Drugs ETF shares in Q2 2019, an estimated $257K.
  • Susquehanna International Group first reported a position in VanEck Vectors Generic Drugs ETF in Q1 2019 and held it in 1 quarter.
  • Susquehanna International Group's VanEck Vectors Generic Drugs ETF position peaked at $257K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held VanEck Vectors Generic Drugs ETF as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.